Skip to main content
IDCases logoLink to IDCases
. 2020 Dec 20;23:e01026. doi: 10.1016/j.idcr.2020.e01026

Ecthyma gangrenosum secondary to MRSA in a young patient with chronic kidney disease

Mazin Barry 1,, Ali Alhijji 1, Abdulaziz Alsubaie 1
PMCID: PMC7770524  PMID: 33384925

Abstract

Ecthyma gangrenosum (EG) is a well-recognized dermatological condition classically associated with Pseudomonas aeruginosa infection, however, the association with other bacteria, especially gram positive, is rare. There are only a few reported cases of EG caused by staphylococcal infection. Here, we report a case in a young patient with chronic kidney disease (CKD) presenting with EG secondary to Methicillin Resistant Staphylococcus aureus.

Keywords: Ecthyma, Gangrenosum, Chronic kidney disease, MRSA

Introduction

Ecthyma gangrenosum (EG) is a dermatological disease with characteristic lesions consistent of vesicles which rapidly evolves to pustules and necrotic ulcers with tender erythematous borders, it is typically associated with Pseudomonas aeruginosa blood stream infection in immunocompromised individuals.

We report a case of EG secondary to Methicillin Resistant Staphylococcus aureus (MRSA).

Case presentation

A 19 years-old man presented to our emergency department complaining of bilateral flank pain for one week and multiple skin ulcers for three weeks. The pain was stabbing in nature involving both flanks, associated with dysuria and fever. His pain was progressive and started to interfere with his daily activities. He also complained of multiple painless skin ulcers that started three weeks before as small pustules with erythematous margins that increased in size rapidly then ruptured into deep ulcers. It first appeared on his abdomen then spread to his right thigh over the next three weeks. He is known to have chronic kidney disease (CKD) secondary to Idiopathic Type II Renal Tubular Acidosis (RTA).

He had no history of trauma or any animal/insect bites at site of lesions, no previous similar skin lesions in the past nor any history of skin and soft tissue infections. He is not on any immunosuppressive medications or steroids and has no history of injection drug use. He lives in an urban city with no animal contact, he is not sexually active, and has no hot tub exposure. he is in a good socioeconomic status, no family history of similar presentation.

Vital signs upon presentation showed tachycardia with heart rate of 114 bpm, temperature was 36.7 °C, blood pressure of 118/75 mmHg, and respiratory rate of 15 bpm. No flank tenderness was appreciated upon examination. Local examination of lesions showed multiple pustules with erythematous margins with no tenderness. On his abdomen and right thigh, there were around 20 lesions with different sizes, the biggest was 1 × 2 cm, they were ranging from pustules to grade 2 ulcers with pus discharge [Fig. 1A].

Fig. 1.

Fig. 1

1A) Upper lateral region of the right thigh of the patient showing multiple round ulcerative indurated lesions with erythematous margins varying in size and stage, with necrotic tissue and pus noted in the largest lesion. 1B) Two weeks after treatment with lesions showing improvement and granulation tissue.

Laboratory findings were significant for leukocytosis of 22 × 103/μL, hemoglobin of 11.7 g/dL and a platelet count of 649 × 109/L normal range [150−450 × 109/L]. Creatinine 770 mcmol\L with a baseline of around 450 mcmol\L. His urine culture grew Escherichia coli susceptible to cefuroxime, deep swab for bacterial culture from all twenty lesions grew Methicillin Resistant Staphylococcus aureus (MRSA) that was susceptible to vancomycin and linezolid. Multiple sets of blood cultures did not grow any organism. MRSA screening was positive in axilla and negative in anterior nares and groin. HIV serology was negative. Skin biopsy showed complete ulceration of epidermis and dermis with granulation tissue, ulcerated area showed multiple neutrophils with numerous bacterial colonies of cocci [Fig. 2A & B].

Fig. 2.

Fig. 2

2A) The epidermis is completely ulcerated (curved arrows) and the dermis shows granulation tissue (arrow). The underlying subcutaneous fat is unremarkable (star). 2B) On higher magnification the ulcerated area is made up of numerous inflammatory cells especially neutrophils (pentagon arrow) mixed with bacterial colonies of numerous cocci (arrowheads).

His skin lesions were classic for EG. His risk factor was CKD which has an impact on the immune state.Additionally, the evolving changes of his lesion were classical for EG. Further, the histopathology revealed that the epidermis was completely ulcerated with numerous inflammatory cells especially neutrophils mixed with bacterial colonies of numerous cocci.

He was treated initially with one day of cefepime 2 g IV every 8 h then changed to cefuroxime 500 mg Q12 h for 7 days for his UTI. For EG due to MRSA he was started on linezolid 600 mg PO Q12 h for 4 weeks, with daily wound care and dressing, no debridement was required.

He was discharged on linezolid and seen as follow up in clinic, at 2- and 4-weeks post discharge, lesions showed progressive improvement till all lesions were completely healed (Fig. 1b). At 6 months follow up, he had no relapse of disease.

Discussion

Ecthyma gangrenosum (EG) is a rare dermatological condition, well-recognized for Psedumonas aerogonosa infection with or without septicemia, it has a high risk of mortality in cases where the infection is systemic. EG is classically described as a painless macule that is round, indurated that progresses into an ulcer with a central necrotic black eschar with surrounding erythema. It extends through the epidermis and deep into the dermis and appears as a "punched-out" ulcer [1]. The exact pathogenesis is not well understood, however, it is believed to be due to perivascular bacterial invasion of the media and adventitia of arteries and veins with secondary ischemic necrosis [2]. It can also be associated with a wide range of gram-negative bacteria that have been reported as causative agents [3]. Association with gram-positive organisms are rare, with few cases reported in the literature Table 1. EG secondary to MRSA has been reported in the literature with underlying immunodeficiency as a main risk factor. Predisposing factors includes neutropenia, malignancy, and HIV. Upon further review of cases reported, MRSA was more commonly associated with EG compared to methicillin-susceptible Staphylococcus aureus (MSSA). There are no written guidelines for treating such cases, however, they were managed as skin and soft tissue infections and duration of treatment was based on clinical response. Prognosis is generally favorable if detected early and treated with MRSA targeted therapy [4]. We report the sixth case of EG due to MRSA and the first in a patient with CKD due to RTA, that was successfully treated with medical therapy alone.

Table 1.

Case reports of patients with Staphylococcus aureus Ecthyma Gangrenosum.

Author Nakai et al.
(2008) [4]
Sen et al. (2009) [5] Ungprasert et al. (2013) [6] Dassan et al.
(2015) [7]
J. Ivanaviciene et al. (2016) [8] Santhaseelan et al. (2017) [9]
Medical condition 40-year-old kidney transplant recipient on immunosuppressive therapy 69-year-old male with COPD 40-year-old HIV patient 41-year-old male with Acute Lymphoblastic Leukemia on chemotherapy 54-year-old African American female with metastatic gastric adenocarcinoma on chemotherapy 47-year-old chronic alcoholic man
MRSA vs MSSA MRSA MRSA MRSA MRSA MSSA MRSA
Blood culture (−) (+) (−) (+) (−) (−)
Lesion culture and sensitivity Culture: MRSA and Pseudomonas aeruginosa Culture: MRSA Culture: MRSA Culture: MRSA Culture: MSSA Culture: MRSA
Treatment and duration high dose gentamicin 30 mg/kg for 1 week ampicillin/sulbactam 1 g IV Q6hrs
meropenem 1 g IV Q8hrs
teicoplanin 400 mg IV daily
Vancomycin as in-patient
Linezolid PO for 1 month
Vancomycin for 2 weeks oxacillin IV for 2 weeks Ceftriaxone
Amikacin
Imepenem
Surgical debridement
Outcome Disappeared with no recurrence Died due to septic shock Improved, lost to follow-up Disappeared, no follow-up mentioned Disappeared with no recurrence disappeared after 4 weeks

CRediT authorship contribution statement

Mazin Barry: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing - original draft, Writing - review & editing. Ali Alhijji: Methodology, Validation, Visualization, Writing - original draft, Writing - review & editing. Abdulaziz Alsubaie: Validation, Visualization, Writing - original draft, Writing - review & editing.

Declaration of Competing Interest

The authors report no declarations of interest.

Acknowledgment

The authors have no acknowledgment

Contributor Information

Mazin Barry, Email: mbarry@ksu.edu.sa.

Ali Alhijji, Email: aLi_AH15@hotmail.com.

Abdulaziz Alsubaie, Email: Azeoan@gmail.com.

References

  • 1.Greene S.L., Su W.P., Muller S.A. Ecthyma gangrenosum: report of clinical and bacteriologic aspects of eight cases. J Am Acad Dermatol. 1984;11:781–787. doi: 10.1016/s0190-9622(84)80453-3. [DOI] [PubMed] [Google Scholar]
  • 2.Walls A.C., Frangos J.E., Goralnick E. Ecthyma gangrenosum in a 67-year-old man with chronic lymphocytic leukemia. J Emerg Med. 2012;43:339–341. doi: 10.1016/j.jemermed.2011.09.034. [DOI] [PubMed] [Google Scholar]
  • 3.Reich H.L., Fadeyi D.W., Naik N.S., Honig P.J., Yan A.C. Nonpseud- omonal ecthyma gangrenosum. J Am Acad Dermatol. 2004;50:S114–7. doi: 10.1016/j.jaad.2003.09.019. [DOI] [PubMed] [Google Scholar]
  • 4.Nakai N., Takenaka H., Kishimoto S. Ecthyma gangrenosum without pseudomonas septicemia in a kidney transplant recipient. J Dermatol. 2008;35:585–589. doi: 10.1111/j.1346-8138.2008.00527.x. [DOI] [PubMed] [Google Scholar]
  • 5.Sen H., Inangil G., Sahin L., Dere K., Ozkan S., Dagli G. Ecthyma- gangrenosum-like lesions associated with methicillin-resistant Staphylococcus aureus infection. Int J Infect Dis. 2009;13:e173–5. doi: 10.1016/j.ijid.2008.09.011. [DOI] [PubMed] [Google Scholar]
  • 6.Ungprasert P., Permpalung N., Kue A.P.P., Ammannagari N., Chongnarungsin D. A rare case of ecthyma gangrenosum associated with methicillin-resistant Staphylococcus aureus infection. J Infect Chemother. 2013;19(4):761–763. doi: 10.1007/s10156-012-0498-0. [DOI] [PubMed] [Google Scholar]
  • 7.Dassan M., Kausar H., Irukulla P., Kupfer Y., Seneviratne C. A case of ecthyma gangrenosum caused by MRSA. Chest J. 2015;148(4) 280a–280b. [Google Scholar]
  • 8.Ivanaviciene J., Chirch L., Grant-Kels J.M., Kerr P.E., Finch J. Ecthyma gangrenosum secondary to methicillin-sensitive Staphylococcus aureus. Int J Womens Dermatol. 2016;2(3):89–92. doi: 10.1016/j.ijwd.2016.05.004. Published 2016 Jul 22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Muralidhar R.G.S., Muralidhar V. Non-pseudomonal ecthyma gangrenosum caused by methicillin-resistant Staphylococcus aureus (MRSA) in a chronic alcoholic patient. BMJ Case Rep. 2017 doi: 10.1136/bcr-2017-220983. Aug 3;2017. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from IDCases are provided here courtesy of Elsevier

RESOURCES